Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-06-04

Clinical Trial Update: Comparison of the Cognitive and Behavioral Effects of Eslicarbazepine Acetate and Carbamazepine in Healthy Adults [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing cognitive and behavioral effects of eslicarbazepine acetate vs. carbamazepine in healthy adults to assess tolerability and CNS impact.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbamazepine (Carbamazepine)
  • eslicarbazepine acetate (eslicarbazepine acetate)

Snippet

Sponsor: Stanford University | Conditions: Epilepsy | Phase 4 | Status: COMPLETED | Results posted: 2019-06-04